A $200 Million Heavy Investment: The Future May Allow You to "Print" Your Own Custom Liver
A major scientific research project with $200 million in funding is currently underway in the United States. Its ultimate goal is to use 3D bioprinting technology to create fully functional, custom-made livers for patients. This could potentially put an end to the long waits for organ transplants and the lifelong burden of taking medication.
The project is named the "Personalized Regenerative Immunocompetent Nanotechnology Tissue" (PRINT) program. Funded by the U.S. Department of Health and Human Services, it brings together five leading universities. At its core lies the use of a patient's own cells, combined with advanced bioprinting and regenerative medicine techniques, to manufacture personalized organs that do not require immunosuppressive drugs, truly achieving "made-to-order" organs.
"Developing a universally matched organ has never been done before in the history of transplantation," stated the project lead. The PRINT program faces significant challenges. It needs to 3D print a human-sized organ containing all the necessary cells, blood vessels, and tissue materials, and make it function like a real organ. If successful, the technological platform it creates could pave the way for regenerating other complex organs like hearts, kidneys, and pancreases.
In the United States alone, over 12,000 patients with liver failure face death each year while waiting for a transplant. If this project succeeds, it could not only provide an on-demand source of functional liver tissue, saving countless lives, but also significantly reduce healthcare costs.
To achieve this vision, collaborating partners will utilize patented mRNA reprogramming technology to transform patient cells into ideal stem cells and scale up production to hundreds of billions of liver-specific cells for printing. The entire project spans five years, with total funding reaching up to $176.8 million.
This endeavor is not just about manufacturing an organ; it aims to "change the very foundation of transplantation itself." In the future, organ shortages may become a thing of the past, and the fate of patients could be rewritten.
